Answers are grounded in this paper and cite their sources.
In patients with systolic CHF, ID is common and constitutes a strong, independent predictor of unfavourable outcome. Iron supplementation may be considered as a therapeutic approach in these patients to improve prognosis.
No takes yet. Share an insight, caveat, or question.
Jankowska et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: